Centessa Pharmaceuticals plc
CNTA
$16.44
-$0.56-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.90% | 31.31% | -202.22% | -10.14% | -76.07% |
| Total Depreciation and Amortization | -4.24% | -9.58% | -11.76% | -4.65% | 177.65% |
| Total Amortization of Deferred Charges | -- | -- | -2.78% | 1.32% | -- |
| Total Other Non-Cash Items | 0.50% | -29.85% | 380.16% | 65.90% | 160.90% |
| Change in Net Operating Assets | 413.88% | -319.24% | 831.86% | 376.58% | -21.55% |
| Cash from Operations | 44.67% | -53.53% | -37.84% | 42.80% | 7.90% |
| Capital Expenditure | -- | -- | 100.00% | 20.93% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.18% | -1,426.74% | 237.01% | -7.69% | 21.99% |
| Cash from Investing | 27.96% | -1,426.74% | 236.80% | -7.68% | 22.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.42% | -24.98% | -16.49% | 1,574.94% | 900,516.67% |
| Repurchase of Common Stock | -62.62% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.48% | -70.59% | -53.42% | 1,568.36% | 877,508.33% |
| Foreign Exchange rate Adjustments | 5.83% | -792.69% | 701.59% | -965.45% | -131.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -765.44% | -2,733.93% | 72.84% | 918.55% | 107.98% |